We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D Radiation Therapy Increases Lung Cancer Survival

By HospiMedica staff writers
Posted on 11 Sep 2006
Sophisticated three-dimensional (3D) radiation therapy has been shown to be more effective at curing lung cancer than older two-dimensional (2D) radiation therapy for some patients with early stage lung cancer, according to a new study.

Non-small cell lung cancer (NSCLC) accounts for 87% of all lung cancers diagnosed. More...
At present, the best treatment for stage I NSCLC is surgery or stereotactic radiation therapy (SRT), frequently followed by chemotherapy if the lesion was larger than 3 cm or radiotherapy and chemotherapy if the surgical margin or hilar or mediastinal nodes were positive at the time of operation. The five-year survival rates are very high, with 50-67% of these patients living at least five years after diagnosis if patients had a well-staged stage I NSCLC.

When surgery is not an option because the patient has heart problems or other complications, treatment alternatives include varying types of radiation therapy and chemotherapy, alone or in combination.

In this study, clinicians at the University of Texas M.D. Anderson Cancer Center (Houston, TX, USA) were looking to determine if traditional radiation therapy worked as well as the newer three-dimensional conformal radiation therapy (3D-CRT) at curing patients with early stage non-small cell lung cancer. 3D-CRT was developed to improve upon older types of radiation therapy by allowing clinicians to aim several radiation beams at the tumor to shape or "conform” the radiation to the lung. The strategy of the technology is to customize each beam, allowing doctors to deliver more radiation to the tumor while keeping it away from nearby healthy tissues.

Between 1978 and 2003, 200 patients with medically inoperable stage I NSCLC were treated with radiation therapy alone. Eighty-five received 3D-CRT while 115 received conventional therapy. Thirty-six percent of patients who received 3D-CRT lived five years after diagnosis compared to 10% who received the traditional therapy. Their causes of deaths were more related to intercurrent disease rather than cancer. Local failure was considerably reduced by 3D-CRT compared to conventional radiation therapy.

The findings were published in the September 1, 2006, issue of the International Journal of Radiation Oncology * Biology * Physics.



Related Links:
M.D. Anderson Cancer Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The AI-driven utility-based system supports precision antibiotic prescribing for UTIs (Photo courtesy of 123RF)

AI Algorithm Improves Antibiotic Decision-Making in Urinary Tract Infection

Urinary tract infections (UTIs) are among the most common bacterial infections worldwide and are a major driver of antibiotic use. Inappropriate or overly broad prescribing contributes to antimicrobial... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.